Evofem Biosciences Reports +ve Top-Line Results from Phase 2b Study of Amphora®
02 Dec 2019 //
PR NEWSWIRE
Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora
26 Nov 2019 //
PR NEWSWIRE
02 Dec 2019 //
PR NEWSWIRE
26 Nov 2019 //
PR NEWSWIRE